Finally, Cramer took up a former caller on his request to learn more about Aurinia Pharmaceuticals, a small-capitalization, development-stage biotechnology company known for its lupus treatments. The "Mad Money" host went straight to the source with Aurinia's CEO, Dr. Richard Glickman, to learn more about the company's leading drug, a Phase-3 treatment...